Gurulakshmi Pharma

A pharmaceutical tablet is a solid dosage form of medication that contains active pharmaceutical ingredients (APIs) along with excipients, compressed into a small, typically round or oval shape. It is designed for oral administration and dissolves in the digestive tract to release the drug for absorption. Tablets can be coated, uncoated, scored, or modified-release, depending on their intended use.

Mounjaro 15mg KwikPen is a once-weekly prescription injection used to help manage blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that belongs to a newer class of medicines called incretin mimetics. This medication helps improve blood sugar levels when diet and exercise alone are not enough.

Mounjaro is intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose. The KwikPen device is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 15mg pen holds a total of 60mg of tirzepatide (4 doses x 15mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. This convenient dosing schedule helps maintain steady blood levels and simplifies treatment.

This medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider.

Mounjaro 15mg KwikPen is a once-weekly prescription injection used to help manage blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that belongs to a newer class of medicines called incretin mimetics. This medication helps improve blood sugar levels when diet and exercise alone are not enough.

Mounjaro is intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose. The KwikPen device is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 15mg pen holds a total of 60mg of tirzepatide (4 doses x 15mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. This convenient dosing schedule helps maintain steady blood levels and simplifies treatment.

This medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider.